Documente Academic
Documente Profesional
Documente Cultură
The clinical trial you will be carrying out will be a mini Phase IV trial, also known as a Post
Marketing Surveillance Trial. This trial takes place after the medicine has received regulatory
approval (market authorization) with the aim of providing broader efficacy and safety
information about the medication in large number of patients, subpopulations of patients, and to
compare and/or combine it with other available treatments. These studies pose the lowest risk of
detection of any adverse effects. Data from this trial will be incorporated into my thesis paper,
which seeks to optimize the medication for chronic non-communicable diseases in our country.
If you have completely understood and agreed with the terms and conditions above, please fill
out your details below and sign this application off. Submit me a copy of this paper by the 22nd of
August, 2016 (Monday)
Name:
ID:
Department:
University/Institution:
Contact Number:
Email Address:
__________________________
Signature
Name: __________________________________________________________________
Medication Information
1. Name of Disease/s:
__________________________________________________________________
___________________________________________________________________
4. Generic Name:
___________________________________________________________________
5. Dosage Form:
___________________________________________________________________
8. Severity of each side effect (On a scale of 1-10, with 1 being negligible/minimum severity
and 10 being maximum severity)
_____________________________________________________________________________________________
_
_____________________________________________________________________________________________
_